I've a bit looked at last year's annual report.
Cash: $107m
Main debt: US$200m notes are matured on 1 August 2023.
Net debt in QIN: $165m
Net tangible asset less external MIS grower liability: $482m or $1.24/share
There's no going concern issue, secured notes are not due until 2023, net debt in QIN: $165m.
I think this one has a relatively good asset backup.
Management do have corporate government issues.
The external MIS grower liability $142m arises from the consolidaon of certain MIS for accounting purposes. The liability will be settled with the proceeds arising from the monetisaon of the external MIS grower interests in the Group’s biological assets as detailed in Note 11, and will not require any additional cash contribution from the Group outside of the MIS projects.
- Forums
- ASX - By Stock
- QIN
- Ann: Update on Galderma Contracts
Ann: Update on Galderma Contracts, page-73
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online